Dr
Giuseppe Schettino
(Queen's University Belfast)
17/10/2012, 13:30
New Cancer Treatment Modalities
oral (invited speaker)
Over the last couple of decades, nanoparticles have attracted considerable interest for their possible use and exploitation in a wide range of applications. For radiotherapy, doping cancerous cells with high Z materials represents an ideal way to boost the dose to the tumour volume without compromising the dose to the healthy normal surrounding tissues. Gold nanoparticles (GNPs) in particular...
Dr
Anna Friedl
(University of Munich, Department of Radiation Oncology)
17/10/2012, 14:00
New Cancer Treatment Modalities
oral (invited speaker)
Radiotherapy using charged particles has attracted increasing interest. The superior dose distribution of protons and heavy ions is hoped to translate into excellent dose conformation to the target and sparing of normal tissues. Whether the potential improvements in outcome justify the costs of particle therapy is, however, heavily discussed. The high costs are mainly due to the higher...
Ms
sally sheim
(NCCCR)
17/10/2012, 14:30
New Cancer Treatment Modalities
oral (20 minutes)
PURPOSE: To determine indications for the use of an IMRT technique for large volume size left breast cancers.
MATERIALS/METHODS: Retrospective review of Stage 0-III left breast cancers with large volumes treated with conservation therapy from April 2011 to January 2012. Computer tomography simulation was used to design fields. Patients were treated supine and received 2 Gy fractions to 50...
Dr
Antonio Carlino
(Physics Department, University of Palermo, Italy; Biophysics, GSI Darmstadt, Germany;INFN Section of Catania, Italy), Prof.
Marco Durante
(Biophysics, GSI Darmstadt, Germany; Physics Department, Technische Universitat Darmstadt Germany)
17/10/2012, 14:50
New Cancer Treatment Modalities
oral (20 minutes)
Heavy-ions beams offer several advantages compared to other radiation such as low lateral scattering and high biological effectiveness (RBE) in the Bragg peak region, making them particularly attractive for the treatment of radio-resistant tumors localized close to organs at risk [1]. To cope with these unique properties, a dedicated treatment planning system (TPS), TRiP98, was developed and...
Dr
Francesco Dionisi
(ATREP Agenzia provinciale per la Protonterapia, APSS Trento)
17/10/2012, 15:10
New Cancer Treatment Modalities
oral (20 minutes)
Purpose: To investigate the “state of the art” of proton therapy in the management of hepatocellular carcinoma (HCC) in terms of 1) the worldwide adoption of this technique , 2) the proton delivery modality and 3) the treatment toxicity and the reported outcome.
Materials and Methods: A systematic review of published reports for the period 1985-2012 was performed according to the PRISMA...
